Home › Research › Risk genes beyond APOE
IMAGING OF THE BONE ARCHITECTURE IN THE CONTEXT OF ALZHEIMER DISEASE
Vidyani Suryadevara, Anuradha Kambrath Valiya, CJ Krehbial, S Karra, Michael Klüppel, MS Willis. Osteoarthritis Imaging, 2026-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Female Psen1 mutation(L166P) mice were found to have reductions in whole-body mineral density (BMD) and bone mineral content as early as one month and a sustained bone phenotype with age with loss in cortical and trabecular properties compared to age-and gendermatched wildtype control mice, whereas male mice did not (Fig.1A-C). In Tau P301S (PS19) Tg+ mice, the cortical and trabecular properties were altered mostly in males, whereas the biomechanical properties were altered both in male and female mice (Fig.1E). FDD Tg+ mice, which show amyloid, tau, and neuroinflammation, had alterations in cortical, trabecular and mechanical properties in both males and females at 12 months and increased bone resorpion (Fig.1F). Generally, among all murine cohorts, PSEN, APP (Fig. 1D) and Tau protein expression is observed in the bone, a potential crosstalk between the brain and the bone in AD. Our imaging studies in preclinical models of AD suggest sex-specific changes in the bone during onset of amyloid pathology (Table1), indicating OA phenotype during AD.
What this study adds
Evidence grade: Low
In several mouse models of Alzheimer's disease, imaging showed sex-specific changes in bone architecture, with female Psen1 mutant mice showing reduced bone mineral density early and sustained bone loss. This is a preclinical animal study and does not test any treatment, cure or prevention for Alzheimer's disease in people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Suryadevara, V., Valiya, A. K., Krehbial, C. J., Karra, S., Klüppel, M., & Willis, M. S. (2026). IMAGING OF THE BONE ARCHITECTURE IN THE CONTEXT OF ALZHEIMER DISEASE. Osteoarthritis Imaging. https://doi.org/10.1016/j.ostima.2026.100445
Vancouver
Suryadevara V, Valiya AK, Krehbial CJ, Karra S, Klüppel M, Willis MS. IMAGING OF THE BONE ARCHITECTURE IN THE CONTEXT OF ALZHEIMER DISEASE. Osteoarthritis Imaging. 2026. doi:10.1016/j.ostima.2026.100445. PMID: 42622180.
BibTeX
@article{suryadevara2026-42622180,
author = {Suryadevara, Vidyani and Valiya, Anuradha Kambrath and Krehbial, CJ and Karra, S and Klüppel, Michael and Willis, MS},
title = {{IMAGING OF THE BONE ARCHITECTURE IN THE CONTEXT OF ALZHEIMER DISEASE}},
journal = {Osteoarthritis Imaging},
year = {2026},
doi = {10.1016/j.ostima.2026.100445},
pmid = {42622180},
url = {https://doi.org/10.1016/j.ostima.2026.100445}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Female Psen1 mutation(L166P) mice were found to have reductions in whole-body mineral density (BMD) and bone mineral content as early as one month and a sustained bone phenotype with age with loss in cortical and trabecular properties compared to age-and gendermatched wildtype control mice, whereas male mice did not (Fig.1A-C).
- In Tau P301S (PS19) Tg+ mice, the cortical and trabecular properties were altered mostly in males, whereas the biomechanical properties were altered both in male and female mice (Fig.1E).
- FDD Tg+ mice, which show amyloid, tau, and neuroinflammation, had alterations in cortical, trabecular and mechanical properties in both males and females at 12 months and increased bone resorpion (Fig.1F).
- Generally, among all murine cohorts, PSEN, APP (Fig. 1D) and Tau protein expression is observed in the bone, a potential crosstalk between the brain and the bone in AD.
- Our imaging studies in preclinical models of AD suggest sex-specific changes in the bone during onset of amyloid pathology (Table1), indicating OA phenotype during AD.
Why it matters
In several mouse models of Alzheimer's disease, imaging showed sex-specific changes in bone architecture, with female Psen1 mutant mice showing reduced bone mineral density early and sustained bone loss. This is a preclinical animal study and does not test any treatment, cure or prevention for Alzheimer's disease in people.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 27 of the 64 points we could judge it on, which is 42 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Osteoarthritis Imaging) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42622180) |
| Free to read | 2 / 2 | Free to read |
| Points | 27 / 64 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 27 of the 64 points we could judge it on is 42 out of 100. |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk genes beyond APOE from nearby years
Also in Risk genes beyond APOE
104 studies in the library are filed under Risk genes beyond APOE with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk genes beyond APOE hub.